期刊文献+

血浆α2巨球蛋白水平与小动脉闭塞型脑梗死发病及认知功能的关系 被引量:7

Correlations of plasma alpha2-macroglobulin levels with small-artery occlusion and cognitive function
原文传递
导出
摘要 目的 探讨血浆α2巨球蛋白(α2-MG)水平与小动脉闭塞型(SAO)脑梗死发病及认知功能的关系.方法 在青岛大学附属医院神经内科自2012年12月至2013年9月收治的患者中选取符合TOAST分型中SAO型脑梗死患者58例(SAO组)、大动脉粥样硬化型(LAA)脑梗死患者56例(LAA组)以及同期体检健康的正常者53例(健康对照组),应用酶联免疫吸附测定法(ELISA)检测血浆α2-MG水平并比较组间差异,绘制受试者工作特征曲线(ROC)判断血浆α2-MG水平对SAO型脑梗死的诊断价值.同时对SAO组进行简易精神状态量表(MMSE)测评,并对其颅脑MRI进行Fazekas评分评判脑白质损害(WMLs)程度,比较不同WMLs程度患者血浆α2-MG水平差异,分析血浆α2-MG水平与MMSE量表评分及Fazekas评分的相关性.结果 与LAA组[(5.04±1.93) μg/mL]、健康对照组[(4.86±1.68) μg/mL]相比,SAO组血浆α2-MG水平[(6.70±3.17)μg/mL]明显增高,差异均有统计学意义(P<0.05);二元Logistic回归分析显示血浆α2-MG水平是SAO型脑梗死的独立危险因素(OR=1.409,P=0.001;OR=1.443,P=0.004).ROC曲线显示4.23μg/mL α2-MG水平为诊断SAO型脑梗死的最佳临界值,灵敏度可达86.2%.不同WMLs程度的SAO型脑梗死患者间血浆α2-MG水平差异有统计学意义(F=26.509,P=0.000),且血浆α2-MG水平与Fazekas评分呈正相关(r=0.733,P=0.000),与MMSE量表评分呈负相关(r=-0.679,P=0.000).结论 α2-MG可作为诊断SAO型脑梗死的血浆标志物,是其独立危险因素,且其水平与认知功能障碍程度及WMLs程度密切相关. Objective To investigate the relationships of plasma alpha2-macroglobulin (α2-MG) level with occurrence of small-artery occlusion (SAO) and cognitive function in SAO patients.Methods Subjects were collected in our hospital from December 2012 to September 2013;58 patients with SAO stroke,56 with large artery atherosclerosis (LAA) classified by Trial of Org 10172 in Acute Stroke Treatment (TOAST),as well as 58 healthy controls,were enrolled.The serum α2-MG levels were measured by enzyme-linked immunosorbent assay (ELISA) and compared among the three groups.The receiver operating characteristic (ROC) curve was drawn to evaluate the value of α2-MG as a biomarker for SAO.White matter lesions (WMLs) were assessed by MRI using Fazekas classification,and mini-mental state examination (MMSE) was used to evaluate the cognitive function.The correlations of plasma α2-MG level with both Fazekas scores and MMSE scores were analyzed.Results The serum α2-MG levels in SAO patients ([6.70±3.17] μg/mL) were significantly higher than those in LAA patients ([5.04±1.93] μg/mL) and controls ([4.86±1.68] μg/mL) (P〈0.05).Binary Logistic regression analysis showed that the plasma α2-MG level was an independent risk factor for occurrence of SAO (OR=1.409,P=0.001;OR=1.443,P=0.004).The ROC curves obtained that α2-MG=4.23 μg/mL was the cutoff values for SAO,enjoying sensitivity up to 86.2%.SAO patients with different severities of WMLs had significantly different serum α2-MG levels (F=26.509,P=0.000);the serum α2-MG levels were positively correlated with Fazekas scores (r=0.733,P=0.000) and negatively correlated with MMSE scores (r=-0.679,P=0.000).Conclusions Serum α2-MG level is an independent risk factor for SAO and might be a biomarker for SAO.Furthermore,serum α2-MG level,being associated with high-grade WMLs,might contribute to evaluating the cognitive impairment in SAO patients.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2015年第5期483-486,共4页 Chinese Journal of Neuromedicine
基金 山东省自然科学基金(ZR2013HM022)
关键词 Α2巨球蛋白 小动脉闭塞型脑梗死 脑白质损害 认知功能障碍 Alpha2-macroglobulin Small-artery occlusion White matter lesion Cognitive impairment
  • 相关文献

参考文献12

  • 1Adams HP Jr, Bendixen BH, Kappelle I_2, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment[J]. Stroke, 1993, 24(1): 35-41.
  • 2Lavados PM, Sacks C, Prina L, et al. Incidence, case-fatality rate, and prognosis of ischaemic stroke subtypes in a predominantly Hispanic-Mestizo population in Iquique, Chile (PISCIS project): a community-based incidence study[J]. Lancet Neurol, 2007, 6(2): 140-148.
  • 3LaMarre J, Wollenberg GK, Gauldie J, et al~ Alpha 2-macroglobulin and serum preferentially counteract the mitoinhibitory effect of transforming growth factor-beta 2 in rat hepatocytes[J]. Lab Invest, 1990, 62(5): 545-551.
  • 4Nezu T, Hosomi N, Aoki S, et al. Alpha2-macroglobulin as a promising biomarker for cerebral small vessel disease in acute ischemic stroke patients[J]. J Neurol, 2013, 260(10): 2642-2649.
  • 5Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging [J]. AJR Am J Roentgenol, 1987, 149(2): 351-356.
  • 6Andus T, Gross V, Tran-Thi TA, et al. The biosynthesis of acute-phase proteins in primary cultures of rat hepatocytes[J]. Eur J Biochem, 1983, 133(3): 561-571.
  • 7Matsuda T, Hirano T, Nagasawa S, et al. Identification of alpha 2-macroglobulin as a carrier protein for IL-6[J]. J Immunol, 1989, 142(1): 148-152.
  • 8Rehman AA, Ahsan H, Khan FH. alpha-2-Macroglobulin: a physiological guardian[J]. J Cell Physiol, 2013, 228(8): 1665-1675.
  • 9Cvim G, Gallistl S, Koestenberger M, et al. Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasma[J]. Thromb Res, 2002, 105(5): 433-439.
  • 10Satizabal CL, Zhu YC, Mazoyer B, et al. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study [J]. Neurology, 2012, 78(10): 720-727.

二级参考文献22

  • 1王小娟,彭卫平,杨桂凤,杨桂芝.脑梗死后血管性认知障碍的相关因素[J].脑与神经疾病杂志,2010,18(5):347-349. 被引量:6
  • 2Noble JM, Manly JJ, Schupf N, et al. Association of C-reactive protein with cognitive impairment[J]. Arch Neurol, 2010, 67(1): 87-92.
  • 3Umemura T, Kawamura T, Umegaki H, et al. Endothelial and inflammatory markers in relation to progression of ischaemic cerebral small-vessel disease and cognitive impairment: a 6-year longitudinal study in patients with type 2 diabetes mellitus [J]. J Neurol Neurosurg Psychiatry, 2011, 82(11): 1186-1194.
  • 4Bernstein IH, Lacritz L, Barlow CE, et al. Psychometric evaluation of the Montreal Cognitive Assessment (MoCA) in three diverse samples[J]. Clin Neuropsychol, 2011, 25(1): 119-126.
  • 5Birkenhager WH, Forette F, Seux ML, et al. Blood pressure, :ognitive functions, and prevention of dementias in older patients with hypertension[J]. Arch Intern Med, 2001, 161(2): 152-156.
  • 6Mogi M, Horiuchi M. Neurovascular coupling in cognitive impairment associated with diabetes mellitus[J]. Cite J, 2011, 75 (5): 1042-1048.
  • 7Crosby-Nwaobi R, Sivaprasad S, Forbes A. A systematic review of the association of diabetic retinopathy and cognitive impairment in people with Type 2 diabetes[J]. Diabetes Res Clin Pract, 2012, 96 (2): 101-110.
  • 8Kravitz BA, Corrada MM, Kawas CH. Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old [J]. Alzheimers Dement, 2009, 5(4): 318-323.
  • 9Marioni RE, Stewart MC, Murray GD, et al. Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future :ognitive decline in individuals without dementia [J]. Psychosom Med, 2009, 71(8): 901-906.
  • 10Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J]. Circulation, 2003, 107(3): 499-511.

共引文献46

同被引文献65

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部